CCX-872

N/A

Report date: 2025/05/06 20:00:08
NME

Base Information

Drug NameCCX-872
Drug Alias NameCCX-872CCX-872-B
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 2 antagonists
TargetsC-C chemokine receptor type 2
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChemocentryx
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of RochesterAmgen Inc
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A